3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
2
Uveal Melanoma
1
Melanoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Hyperthermia
1
Fallopian Tube Neoplasms
1
Eye Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Burkitt Lymphoma
1
Interventions
Paclitaxel
56
Carboplatin
56
Bevacizumab
43
Gemcitabine
20
Taxes
19
pembrolizumab
15
Immunoglobulin G
13
Disulfides
13
Topotecan
12
olaparib
11
Cisplatin
11
niraparib
9
Cyclophosphamide
9
liposomal doxorubicin
8
Specimen Handling
7
Docetaxel
6
Biopsy
6
mirvetuximab soravtansine
5
Nivolumab
5
Magnetic Resonance Spectroscopy
5
Letrozole
5
Hyperthermic Intraperitoneal Chemotherapy
5
Drug Therapy
5
Cytoreduction Surgical Procedures
5
Albumin-Bound Paclitaxel
5
rucaparib
4
pazopanib
4
oregovomab
4
Surgical Procedures, Operative
4
Neoadjuvant Therapy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Fallopian Tube Neoplasms
×
Laparotomy
×
Clear all
NCT00008138
2016-01-08
S0009
SWOG Cancer Research Network
Phase 2
Completed
62 enrolled
9 charts